Psychometric properties of the Lithuanian version of the NDDI-E in persons with epilepsy and suicidal ideation

Puteikis, Kristijonas; Mameniškienė, Rūta

doi:10.1016/j.yebeh.2022.108913

Cited by 1 publication

(2 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Secondary outcomes will include symptoms of depression (Neurological Disorders Depression Inventory in Epilepsy, NDDI-E) ( 13 , 14 ), anxiety (General Anxiety Disorder-7, GAD-7) ( 15 ) and suicidality (Columbia Suicide Severity Rating Scale, C-SSRS) ( 16 ), metacognition (Metacognition Questionnaire-30, MCQ-30) ( 17 , 18 ), Jacoby’s 3-item Stigma Scale ( 19 ), antiseizure drug adverse effects (Liverpool Adverse Events Profile, LAEP) ( 20 , 21 ), health-related quality of life [the Short Form (36) Health Survey] ( 22 ) and subjective evaluation of cognitive functions ( ad hoc Likert scales 0 to 10). Secondary cognitive outcomes will include reaction speed (Trail Making Tests A and B, Maze Task), working memory (Digit Span Test), verbal fluency (categorical and phonemic naming in 60 s), autobiographical memory (naming of recent personal autobiographical events), delayed verbal story recall as well as 1-week verbal recall to test for accelerated long-term forgetting.…”

Section: Discussionmentioning

confidence: 99%

“…The psychosocial status of the patient will be evaluated to adjust for subclinical levels of anxiety and depression as well as to see whether CoRE may improve patient mental health. Moreover, we will also investigate suicidality – this part of the evaluation is rarely done in the clinical setting and is especially important in Lithuania, which has extremely high suicide rates ( 14 ). Patients will also complete a metacognition questionnaire – a relatively novel tool in PWE set to assess coping and thinking mechanisms that underlie self-regulation in psychopathology and may help to explain better response to CoRE ( 17 , 18 ).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Rehabilitation of cognition and psychosocial well-being – a better life with epilepsy (ReCaP-ABLE): a protocol for a randomized waitlist-controlled trial

Puteikis,

Jakonienė,

Jasionis

et al. 2023

Front. Neurol.

Self Cite

View full text Add to dashboard Cite

Despite advances in the understanding of cognitive dysfunction among people with epilepsy (PWE), evidence for cognitive rehabilitation in epilepsy (CoRE) remains scarce. We present the protocol of a randomized waitlist-controlled trial (ClinicalTrials.gov ID NCT05934786) of a psychological-behavioral intervention aiming to ameliorate quality of life as well as cognitive functioning in a mixed PWE sample. The study is set at Vilnius University Hospital Santaros Klinikos and will offer adult PWE six individual and two group sessions led by a certified psychologist and directed toward improving memory, attention, self-regulation, mood and quality of life. The trial is expected to address major gaps in the literature by providing novel evidence on the effectiveness of CoRE in patients with genetic generalized epilepsies, the importance of epilepsy-specific factors for the response to CoRE, the impact of CoRE on long-term memory as well as its maintenance effects.

show abstract